LANDOS BIOPHARMA INC's ticker is LABP and the CUSIP is 515069102. A total of 36 filers reported holding LANDOS BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $418,000 | -69.2% | 283,217 | 0.0% | 0.01% | -58.8% |
| Q4 2021 | $1,359,000 | -67.1% | 283,217 | 0.0% | 0.02% | -62.2% |
| Q3 2021 | $4,135,000 | -47.4% | 283,217 | -58.4% | 0.04% | -43.8% |
| Q2 2021 | $7,866,000 | +19.9% | 681,000 | 0.0% | 0.08% | +31.1% |
| Q1 2021 | $6,558,000 | – | 681,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 1,612,764 | $1,174,000 | 1.62% |
| Perceptive Advisors | 14,869,915 | $10,823,000 | 0.34% |
| RTW INVESTMENTS, LP | 4,275,722 | $3,112,000 | 0.08% |
| ArchPoint Investors | 127,262 | $93,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 149,000 | $108,000 | 0.00% |
| Ergoteles LLC | 22,900 | $17,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 40,280 | $29,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,043 | $3,000 | 0.00% |
| NORTHERN TRUST CORP | 12,219 | $9,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |